Operating Metrics 營運指標
Moderna, Inc. (MRNA) Operating Metrics 營運指標
Moderna, Inc. MRNA 最近 7 季公司營運 KPI、指標定義、跨期趨勢與官方來源。
資料截至：2026-06-30
最新營運指標
- COVID Vaccine Product Sales
- $91M · 2026-06-30 來源：U.S. Securities and Exchange Commission
- RSV Vaccine Product Sales
- $3M · 2026-06-30 來源：U.S. Securities and Exchange Commission
季度趨勢
| 指標 | Q2 FY2026 | Q1 FY2026 | Q4 FY2025 | Q3 FY2025 | Q2 FY2025 | Q1 FY2025 | Q4 FY2024 | Q3 FY2024 |
|---|---|---|---|---|---|---|---|---|
| COVID Vaccine Product Sales | $91M | $345M | — | $971M | $114M | $84M | $923M | $1,810M |
| RSV Vaccine Product Sales | $3M | $7M | — | $2M | $0M | $2M | $10M | — |
資料來源
- Moderna, Inc. Q2 2026 Form 10-Q · U.S. Securities and Exchange Commission
- Moderna, Inc. Q1 2026 Form 10-Q · U.S. Securities and Exchange Commission
- Moderna Reports Third Quarter 2025 Financial Results · U.S. Securities and Exchange Commission
- Moderna Reports Second Quarter 2025 Financial Results · U.S. Securities and Exchange Commission
- Moderna Reports First Quarter 2025 Financial Results · U.S. Securities and Exchange Commission
- Moderna Reports Fourth Quarter and Fiscal Year 2024 Financial Results · Moderna, Inc.
- Moderna, Inc. Q3 2024 Form 10-Q · U.S. Securities and Exchange Commission